Discussed On
Episodes
Pharma and BioTech Daily · Apr 23, 2026
Amneal's $1.1B Biosimilars Move & Merck's HIV Pill | Pharma and Biotech Daily
Biosimilars Market ExpansionAI Integration in Drug DiscoveryCAR-T Therapies for Autoimmune DiseasesGLP-1 Receptor Agonist CompetitionHIV Treatment Innovation
View AnalysisThe a16z Show · Feb 16, 2026
Novartis CEO Vasant Narasimhan on Transforming a 250-Year-Old Company
Corporate transformation and spin-offsCell and gene therapy platformsRNA therapeutics and siRNA technologyRadioligand therapy manufacturingChina biotech competition
View Analysis